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This thesis aimd to investigate the evidence up to date for diet as the treatment for ADHD. In 
order to do this several articles on different nutritional supplements, as well as whole diets, 
were reviewed.  
 
I have a special interest in the gut microbiota, sickness as consequence of Western lifestyle, 
and paediatrics. Therefore, I choose children with ADHD and diet as topic for this thesis. I 
contacted professor Eyvind J. Paulssen, at the Department of Clinical Medicine at UiT The 
Arctic University of Tromsø, who I remembered for his lectures about gut-health and also for 
punctilious training in journal writing, and asked for his mentoring. I also got guidance on 
ADHD in children by Dr. Judeson Joseph, lecturer in Child and Adolescent Mental Health at 
the Department of Clinical Medicine.  
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Background: Attention deficit hyperactivity disorder, ADHD, is estimated to be the most 
common behavioural disorder in children, affecting 6-12% of children worldwide (1). The 
condition has only a few options for evidence-based treatment (2), and public accessible 
numbers from The prescription register of the Norwegian National Institute of Public Health 
have shown more than a threefold increase in the use of medication for ADHD since 2004 (3). 
Studies have shown an association between ADHD and western dietary pattern (4), and there 
seems to be an increasing interest in whether diet influences the symptoms or not. 
 
Objectives: This study aims to collect the most recent studies, and their results, on diet as the 
treatment for ADHD, to determine if there is any conclusive data that can be clinically used 
today.  
 
Methods: The study is an evaluation of published literature, selected through a defined 
search strategy in PubMed, U.S National Library of Medicine National Institutes of Health.  
 
Results: A total of 21 articles met the inclusion criteria, some investigating the effect of 
dietary supplements and some investigating the effect of whole diets.  
 
Discussion: The result of this study does not give a defined answer around diet as the 
treatment for ADHD, nevertheless it points out some interesting findings for further 
investigation.  
 
Conclusions: Despite compelling evidence for Omega-3 polyunsaturated fatty acids as a 
treatment for ADHD, the effects of other nutritional supplements are not negligible and 





Attention deficit hyperactivity disorder, ADHD, is estimated to be the most common 
behavioural disorder in children, affecting 6-12% of children worldwide. The International 
Classifications of Diseases 10th edition, ICD-10, describes ADHD as consisting of three main 
symptoms, inattention, hyperactivity and impulsivity, that must be present for more than six 
months and manifest before the age of seven (1).  
 
The prevalence of ADHD in the Norwegian population is assumed to be 3-5%, where the 
male-to-female sex ratio is 4:1. The difference between the sexes is explained as a general 
higher activity level in boys, and that the main symptom in girls is inattention, and therefore 
harder to discover (5).  
 
Public accessible numbers from The prescription register of the Norwegian National Institute 
of Public Health have shown more than a threefold increase in the use of medication for 
ADHD since 2004 (3). The condition has only a few options for evidence-based treatment, 
including pharmacotherapy, behavioural intervention, psychotherapy interventions and 
School-based interventions (2). Pharmacotherapy is currently considered as the cornerstone 
of evidence-based treatment for ADHD, and over 70% of affected children respond to 
psychostimulant medication (6). Nevertheless, there is a lack of evidence of long-term 
efficacy and the side effects associated with these pharmacological treatments have led to a 
search for other alternatives (7). Thus non-medical treatment is sought after by patients and 
parents alike. 
 
Studies have shown an association between ADHD and Western dietary pattern (4), and there 
seems to be an increasing interest in whether diet influences on the symptoms or not. There 
are several approaches in ways of treating ADHD with diet, including change of the 
participants’ entire diet, adding special groups of food to their diet, such as white fish, 
remove specific foods from the diet, such as sugar or food colourant, or adding one or several 
nutrients to the diet in form of capsules containing them. This review will focus on studies 





This study is written as an evaluation of published literature that has ADHD and diet as a 
topic. The collection of studies to be reviewed was selected by a search in PubMed, U.S 
National Library of Medicine National Institutes of Health, 2019-06-21, using the search 
strategy “Attention Deficit Disorder with Hyperactivity [mh] AND (Diet [mh] OR food [mh]).” 
Inclusion criteria were articles published after 2013-12-31 with full text available. The 
described research had to be done on humans between 0-18 years, and could not be based 
on prenatal status, mother’s health during pregnancy or way of birth. The search was further 
limited to clinical trials, reviews and meta-analyses. Trials were included if they examined 
treatment regiments for ADHD, and were randomized and placebo-controlled trials.  
 
Among the resulting 62 articles, there were a few letters or comments to other published 
articles. These were not included nor reviewed. The search also resulted in articles with topics 
that included the search words but did not study diet as the treatment of ADHD, and were 
therefore not included. The final resulting number of articles was 20.  





The result consists of 20 articles studying different nutritional 
ways to treat ADHD. The outcome has been categorized 
according to which foods the authors propose as treatment.  
4.1 Dietary supplements 
4.1.1 Polyunsaturated Fatty Acids 
The majority of the articles reviewed, ten in total, involved the study of polyunsaturated fatty 
acids, PUFA, as the treatment for ADHD. PUFA’s are essential acids, that cannot be 
synthesized by humans and thus are required in our diet (8). Eicosapentaenoic acid, EPA, and 
docosahexaenoic acid, DHA, are the two main bioactive forms of omega-3 polyunsaturated 
fatty acids in humans. These can be synthesized from the essential fatty acid α-linolenic acid. 
Omega-3 PUFAs are generally associated with anti-inflammatory effects, in comparison to 
omega-6 PUFAs, synthesized from the essential fatty acid linoleic acid, which are linked to 
pro-inflammatory effects (9). A high omega-6 to omega-3 fatty acid ratio could promote 
inflammation in the human body, including neuroinflammation. Increased omega-3 fatty acid 
concentration may alter central nervous system cell membrane fluidity and phospholipid 
composition, which may change the structure and function of the proteins embedded in it. 
The neurotransmission of dopamine and serotonin have shown to be affected by increased 
omega-3 fatty acids concentration in the cell and may be of importance in ADHD 
pathogenesis. Omega-3 fatty acids may also potentially reduce oxidative stress, which has 
been demonstrated to be elevated in ADHD (10).  
 
The importance of omega-3 fatty acids in neural brain tissues is strongly suggested by 
membrane enrichment in these tissues. In the adult frontal cortex, the total amount of fatty 
acid consists of 15-20% DHA, and in neural tissues, it makes upward of 50% of 
polyunsaturates. These enrichments play an essential role in assuring the correct 
environment for membrane protein function and membrane fluidity. Deficiency of omega-3 
fatty acids promotes a destructive effect related to brain and neurologic function, including 
inhibition of brain maturation and neuroplasticity and abnormalities in neurotransmitter 
function. If the deficiency occurs during neural development, it might give persistent adverse 
Fig. 2: Table of how the articles distribute 




developmental outcome. Fatty acid pools are directly influenced by dietary fatty acid intake. 
Dietary supplementations with fish oil results in an increased proportion of EPA and DHA 
within biological membranes, frequently at the expense of arachidonic acid. When dietary 
omega-3 levels are low, an imbalance of pro-inflammatory eicosanoids may occur as 
eicosanoids such as prostaglandins, thromboxane, and other oxidative metabolites derived 
from arachidonic acid, facilitate neuroinflammation. EPA and DHA are metabolized to 
resolvins and protectins, which are recently identified molecules, seen to be very potent anti-
inflammatory mediators in cellular and animal model systems (11,12). 
 
Widenhorn-Muller et al. (13) found that supplementation with mixes of omega-3 fatty acids 
increased EPA and DHA concentrations in erythrocyte membranes and this correlated 
significantly with improved memory function in 46 children diagnosed with ADHD according 
to DSM-IV criteria. The improved working memory also correlated significantly with 
decreased arachidonic acid, but supplementation did not affect other cognitive measures nor 
parent and teacher-rated behaviour. There were no healthy control group in the study, and 
therefore it is not known if the effect is only seen in children with ADHD, or if this will be the 
result for whoever takes the supplement used in the study.  
 
A review from the same year, written by Rucklidge and Kaplan (7), suggest that there in 2014 
was CEBM, Oxford Centre of Evidence-Based Medicine, level-1 evidence demonstrating the 
efficacy of omega 3 fatty acids for the treatment of ADHD. The recommendation is 
supplementation with a dose of 1-2 g daily, with a substantial content of EPA within the 
formulation.  
 
A review by Gumpricht and Rockway (12) on neurodevelopmental disorders, NDD, ADHD, as 
well as autism and apraxia, states that the compelling evidence for increased oxidative stress, 
altered antioxidant defences and neuroinflammation in these children gives a rationale for 
adding omega -3 fatty acids to these children’s diet. Extensive literature suggests increased 
oxidative stress occurs in children with NDD. As a corollary to these findings, other 
researchers found reduced antioxidant defences. There is also evidence for reduced plasma 




and reduced vitamin E levels in children with NDD strongly suggests a need for both vitamin E 
and omega-3 fatty acids as a complementary nutritional therapeutic intervention in these 
children. 
 
A randomized three-way crossover trial by Milte, Paletta and Buckley et al. (14), done in 87 
children aged 6-13 years with ADHD symptoms, compared the effects of supplementation 
with long-chain n-3 PUFAs EPA and DHA with the omega-6 PUFA linoleic acid on literacy, 
attention and behaviour in children with ADHD with and without learning difficulties. A 
correlation was found with regression analysis of blood sample results between increased 
erythrocyte levels of omega-3 and omega-6 PUFA and outcome measures: There were 
negative associations between increased levels of omega-6 PUFA and various outcome 
variables, while increased levels of omega-3 PUFAs were associated with improved literacy, 
attention and parent-rated behaviour. A reduction in the ratio between omega-6 and omega-
3 PUFA were therefore a consistent predictor of improved outcomes. 
 
A meta-analysis published in 2015 by Cooper et al. (15) examined the efficacy of omega-3 
PUFA supplementation on cognitive performance measures in school-aged children and 
adults who were typically developing or had ADHD, or related neurodevelopmental disorder. 
There was not found an effect of the supplementation on cognition in the whole group, or the 
groups analysed separately. A small improvement in short-term memory and working 
memory was seen, in a few studies, in participants with low omega-3 PUFA.  
 
In a double-blind randomized controlled trial by Bos, Oranje, Veerhoek et al. (16) Omega-3 
PUFA dietary supplementation improved symptoms of inattention in boys with and without 
ADHD. The dopamine turnover and neural activity did not change during the intervention; 
therefore the effect did not appear to be mediated by dopaminergic cognitive control 
networks. This indicates that typically developing children also benefit from the intervention, 
and therefore supplementation with omega-3 seems to be important for all children. The 
finding that the result is not mediated by dopaminergic cognitive control measures correlates 
with the findings of Bergwerff and Luman et al. (17) who found that children with ADHD 




protein intake compared to controls. The aromatic amino acids tryptophan, tyrosine and 
phenylalanine are essential in the synthesis of serotonin and dopamine, but no association 
between the disorder’s symptoms and the concentration of these substances were found.  
 
A meta-analysis from 2016 by Cooper, Tye et al. (18) studied the effect of omega-3 PUFA 
supplementation on emotional liability, defined as low frustration tolerance, irritability and 
mood liability. Initial analyses gave no significant effects on emotional liability, oppositional 
behaviour, conduct problems and aggression. However significant effects were seen in 
subgroup analyses on parent-rated emotional liability in studies that met strict inclusion 
criteria. Tendencies of improvement on teacher-rated oppositional behaviour in studies 
supplemented with adequate EPA were also seen. Only a few studies (n=10) with enough 
data could be included in the analysis, which the authors point out as a demonstration of the 
need of further research in the area to gain a more conclusive picture. 
 
In a randomised, double-blind, placebo-controlled trial by Kean, Sarris et al. (19) found that a 
marine oil extract rich in long-chain polyunsaturated fatty acids, named PCSO-524, did not 
improve parent-rated levels of hyperactivity, inattention and impulsivity over placebo in 
children with ADHD, but all children consuming the product significantly improved in 
cognitive tasks compared to the group consuming placebo. 
 
A randomized, placebo-controlled clinical trial by Crippa, Tesei et al. (20) studying the efficacy 
of a 6-month supplementation with DHA as the only treatment in 50 medication-naïve school-
children with ADHD. The primary outcome measure did not show benefit of the treatment on 
an ADHD parent rating scale. Secondary behavioural outcome showed statistically significant 
effects on psychosocial function and a decrease in parent-rated emotional problems, 
although the size of these effects, 0.13 and 0.23, were quite small. All the children in the trial 
had abnormally lower blood levels of DHA at baseline compared to 22 normal developing 
peers matched by IQ, age and gender. The authors state that the study is limited by its small 






There are many metabolic steps in every pathway of neurotransmitters, where each step 
requires enzymes. These enzymes are dependent on multiple and adequate quantities of 
vitamins and minerals, cofactors. Inborn metabolic dysfunction which limits availability of 
micronutrient cofactors, resulting in slow metabolic activity, might cause the psychiatric 
symptoms seen in ADHD (21,22). ATP production is possibly compromised in ADHD, which 
could explain micronutrients potential therapeutic effects through improved mitochondrial 
production of adenosine triphosphate, ATP. Higher production of ATP would give improved 
energy metabolism of neurons and glial cells (7).  
 
Trials of treatment with vitamins and minerals have mainly focused on single nutrients, often 
resulting in mixed and inconsistent effects, most often negligible. This suggests that single 
nutrient interventions do not have an adequate impact on the complex biochemical pathway 
in children with ADHD. An administration of one nutrient could cause an imbalance in other, 
and it is unlikely that a single nutrient would resolve such a complex disorder (7). 
 
The most frequent micronutrients studied in children with ADHD are zinc and iron. Zinc is 
involved in the metabolism of melatonin, prostaglandins and neurotransmitters (23,24). 
Symptoms of zinc deficiency mimic the symptoms of ADHD, and most meta-analyses suggest 
an association between the two. Several clinical trials have shown that zinc supplements are 
superior to placebo in reducing hyperactivity and impulsivity (25). Zinc might also improve the 
effect of amphetamine, the most common ADHD drug (26). This suggests that zinc plays an 
important role in the pathogenesis of ADHD. Iron is a cofactor for the rate-limiting step of 
monoamine synthesis, and therefore critical to producing dopamine and norepinephrine. 
Several studies have shown a correlation between low serum iron levels and ADHD, iron 
deficiency increasing symptoms and iron supplements improving them (25). A case-control 
study by Yang, Zhang et al. (25), the level of zinc was observed significantly lower in ADHD 
group than that in the control group, and they found a moderate correlation between zinc 
level and inattention. None of the other elements, including iron, copper, magnesium and 





As mentioned earlier, according to Gumpricht and Rockway (12), there is evidence for 
reduced plasma levels of vitamin E in children with neurodevelopmental disorders. The 
primary function of vitamin E is to protect membrane polyunsaturated fatty acids against 
oxidative damage and is particularly important in omega-3 fatty acid-enriched neurologic 
tissues. Symptoms of ADHD may frequently overlap with the neurologic symptoms observed 
in vitamin E-deficient patients, although obvious human vitamin E deficiency is only seen in 
individuals with either severe malnutrition or fat malabsorption syndromes, such as children 
with cystic fibrosis or cholestatic liver disease. 
 
An open-label reversal design study by Gordon, Rucklidge, Blampied et al. (27) studied the 
effect of a micronutrient supplement containing 36 different vitamins and minerals; Vitamins 
A, B1-6 + 9 and 12, C, D, E and H, and calcium, iron, phosphorus, iodine, magnesium, zinc, 
selenium, copper, manganese, chromium, molybdenum and potassium. It also contained dl-
phenylalanine, glutamine, citrus bioflavonoids, grape seed, choline bitartrate, inositol, ginkgo 
biloba, methionine, germanium sesquioxide, boron, nickel, and vanadium. During a 6-month 
trial, 14 children with the diagnosis of ADHD, were given this supplement for eight weeks, 
then had no treatment for four weeks, and then treatment for eight new weeks, before the 
treatment was withdrawn for the last four weeks. While taking micronutrients, the great 
majority of participants experienced a statistically and clinically significant reduction in ADHD 
symptoms, improvement in mood, and increase in overall functioning that were reversed 
when the treatment was withdrawn. Benefit was observed by the parents, clinicians, and the 
children themselves. Participants, caregivers and clinicians knew when they were taking and 
not taking the micronutrient, which means the positive responses given may have been 
influenced by expectancy of effect. The contribution of placebo response to the observed 
results cannot be estimated, but a convincing reason why a placebo effect is unlikely to 
explain the entire therapeutic results is that for most participants, the therapeutic effect was 







Different in vivo mechanisms generate reactive oxygen species, ROS, that oxidise agents or 
are easily converted into radicals (28). Mitochondrial energy production is the main source of 
ROS throughout the body, but other reactions contribute. In the central nervous system, 
activated microglia is also an important source (29). ROS are required in low levels for normal 
cell functioning, but radicals are highly reactive, and excess of ROS can therefore damage the 
macromolecules of the cell, and thereby their function (30). A way of reducing free radicals in 
the body is by detoxification by antioxidants (31). A shift in the balance between oxidants and 
antioxidants in favour of oxidants is called oxidative stress, which can damage for example 
macromolecules and DNA (32). ADHD aetiology can be related to multiple effects of oxidative 
stress on the brain, as it can lead to progressive neuronal damage and weakening of normal 
cerebral functions (33).  
 
A review by Verlaet, Maasakkers et al. (30) concludes that a nutritional supplement of 
antioxidants is a potential ADHD therapy as there is a proven association between ADHD and 
oxidant-antioxidant imbalances.  
4.1.4 Probiotics 
It is well recognized that gut microbiota affects the brain’s physiological, behavioural and 
cognitive functions, although the exact mechanism of the gut microbiota-brain axis has not 
yet been fully understood. Evidence from animals and human studies has shown that 
microbiota of the gut has an important role in developing behaviour and cognitive functions 
by producing hormones, immune factors and metabolites, which also indicates that altering 
gut microbiota may improve or cure brain disease (34).  
 
A prospective cohort study by Pärtty et al. (35) found that administration of Lactobacillus 
rhamnosus GG may reduce the risk of ADHD and Asperger’s syndrome. A group of 132 infants 
were randomized to receive the bacteria or placebo during the first 6 months of life and were 
followed up for 13 years. The groups were equal at baseline, and although 57 were lost to 
follow-up, the groups were also equal at the end of the trial, except for duration of exclusive 
breastfeeding. At the age of 13 years, ADHD was diagnosed in 6 out of 35 children in the 




species bacteria, which in mice have shown to have an anxiolytic effect, was significantly 
lower in the faeces of the affected children in the first 6 months of life.  
 
4.1.5 Other 
Cremonte, Sisti et al. (36) did an experimental study on supplementation with the algae 
extract Klamin in children with ADHD. The underlying theory was that current research 
suggests that ADHD can be attributed to interaction between dysfunctional neurotransmitter 
systems, and low levels of phenylethylamine, PEA, which is an endogenous neurotransmitter 
that is normally stored and metabolized in the brain. Klamin contains PEA, which stimulates 
the release of dopamine and catecholamines from intraneuronal reserves in the brain, and 
inhibition of the reuptake of noradrenaline, serotonin and dopamine in neurons. PEA is easily 
degraded by monoamine oxidase B, MAO B, but Klamin also contains AFA-phycocyanins, 
which is a selective inhibitor of this enzyme. Despite the small study it appears to confirm the 
initial hypothesis that Klamin may positively affect the expressions of ADHD symptoms. 
 
4.2 Dietary patterns 
A few studies in the search did not study a nutrient or supplement, but a whole diet and its 
association to ADHD. A case-control study by Zhou, Wu et al. (37) on Chinese children found 
some interesting associations between ADHD and diets: Dietary patterns rich in deep water 
fish, shellfish, freshwater fish, fungi and algae, white meat, and organ meat was inversely 
associated with ADHD. The same association was found in dietary patterns rich in zinc, 
phosphorus, riboflavin, selenium, calcium and protein. Additionally, ADHD was negatively 
related to blood levels of zinc. The study suggests, and support its suggestion with previous 
studies, that healthy dietary patterns, containing vegetable, fresh fruit, fish, white meat and 
whole grains were protective against ADHD, whilst an unhealthy dietary pattern, including 
fast food, ice cream, sweets, snacks and red meat were adversely related to ADHD. Another 
Case-control study by Ríos-Hernández, Alda et al. (38) and a cross-sectional study by Martín, 
Olivares et al. (39) found that lower adherence to the Mediterranean diet was associated with 






A systematic review from 2015 by Rytter, Andersen et al. (40) looked into elimination diet, 
specifically diets without artificial colours and other additives. The studies reviewed did not 
provide any clear or convincing results concerning children with ADHD, however, two large 
studies both found that normal children showed an increase in ADHD-like behaviour after 
receiving a mix of artificial colourants, called “azo-dyes”, together with preservative sodium 
benzoate. The result of this is that the European Union have a law stating that foods 
containing these dyes should have a label warning that they may affect children’s behaviour 
and attention. Meta-analyses reviewed on this issue all concluded that food colourants have a 
small, but statistically significant, effect on ADHD symptoms in some children, although the 
studies were of limited quality. The review also contained five crossover RCT concerning short 
term exposure to sugar and artificial sweeteners, which found no change in core ADHD 
symptoms with either of them.  
 
5 Discussion 
The result of this study does not give a definite answer around diet as the treatment for 
ADHD, nevertheless, it points out some interesting findings for further investigation:  
 
Several of the studies reviewed about polyunsaturated fatty acids found increased memory 
function when taking omega-3 supplements, but the studies do not determine whether this is 
an effect in children with ADHD only, or all developing children (13,15). Compelling evidence 
of oxidative stress, reduced antioxidant defences and neuroinflammation in children with 
ADHD gives rationale for adding PUFAs to these children’s diet, and in 2014 cumulative 
evidence suggested supplementation with 1-2g daily of omega-3 fatty acids with a substantial 
amount of EPA (7,12). Adequate EPA in the supplement also showed a trend of reduced 
emotional liability and teacher-rated oppositional behaviour (18). Supplementation with n-3 
PUFAs compared with n-6 PUFAs improved literacy, attention and behaviour, and a reduced 
omega-6:omega-3 ratio was a predictor for an improved outcome (14).  
 
Regarding micronutrients, trials with single nutrients often resulted in mixed and inconsistent 




is unlikely that a single nutrient would resolve such a complex disorder (7). Clinical trials 
showed zinc to be superior of placebo in reducing hyperactivity and impulsivity, and it might 
improve the effect of amphetamine as treatment for ADHD. The study also found significantly 
lower levels of zinc in children with ADHD then controls, and there was a moderate 
correlation between blood zinc level and inattention (25,26,37).  
 
There is evidence for reduced vitamin E in children with neurodevelopmental disorders, and 
symptoms of ADHD overlap with symptoms of Vitamin E deficiency (12).  
 
A micronutrient containing 36 different vitamins and minerals gave the majority of 
participants, who were not blinded, a gradual therapeutic effect of reduced symptoms, mood 
and overall functioning reported by caretakers, teachers and the children themselves. 
Arguments for that the observed effect is not all placebo, are the gradual effect seen when 
taking the supplement (27).  
 
Two case-control studies studying whole diets found inverse associations between ADHD and 
diets containing vegetable, fresh fruit, fish, white meat and whole grains, whilst an unhealthy 
dietary pattern, including fast food, ice cream, sweets, snacks and red meat were adversely 
related to ADHD. Inverse association were also found in dietary patterns rich in zinc, 
phosphorus, riboflavin, selenium, calcium and protein (37,38).  
 
The use of PubMed as a search engine was chosen because it is standard for medical 
literature.  
 
A strength of this study is that it is a systematic review of the subject. The study could also be 
done as an interview or a survey of treatment personnel. The benefit of using peer-reviewed 
articles is that it will give a general view of current evidence. Reviews of current evidence are 
important in the path forward in clinical research. An interview or survey, on the other hand, 
might have given a picture of the current experiences among therapist on the effect of diet as 
the treatment for ADHD, but the result would be from a local, at best national, point of view, 





Another strength is that it pertains to existing results from child studies and not extrapolating 
on results from adult studies. Research on children for sake of finding treatment for children 
is also a key in clinical research. Though one can imagine a certain hesitance on performing 
research on children, the clinical research in field paediatrics needs to acknowledge the 
necessity for more clinical paediatric research.  
 
A limitation of this study is that the search gave a low number of articles and that several of 
the included studies have small sample sizes. The only supplement with a tolerably number of 
studies where found on polyunsaturated fatty acids, where there were found nine, but other 
supplements or diets only had up to three articles. The primary reason for this is that the 
inclusion criteria might be too limitable. The first criteria were that the article was published 
in 2014 or later. By excepting articles published further back in time there would be more 
data to review. Second, the search was limited to humans, specifically children. The reason 
for this is that it might be difficult to know if results are transferable to humans if done on 
animals. The same goes for excluding studies done on adults, although it would be interesting 
to compare findings in adults versus children and see if the trends found in this study also are 
present in adults. The reason for excluding research done on prenatal health, mothers health 
during pregnancy and way of birth is that it cannot be used as treatment.  
 
6 Conclusion 
Although there is compelling evidence for omega-3 as a treatment for ADHD, the effects of 
other nutritional supplements as well as whole diets is not negligible and suggest not only 
specific nutrients but also whole diets should be considered both preventive and as the 
treatment for ADHD.   
 
Some of the challenges in clinical research is that nutritional interventions, including dietary 
eliminations, demand resources, compliance and long-time follow-ups. Studies with greater 
sample sizes and more controlled trials are needed to show effects that can be sufficient to 
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